TG and familial hyperaldosteronism: Treatment strategies in the management of FH have investigated the potential role of certain additional options, including microsomal transfer protein inhibitors, liver-selective thyroid hormone mimetics, and oligonucleotides that supress ApoB (mipomersen; European Association for Cardiovascular Prevention and Rehabilitation et al., 2011; Hovingh et al., 2013).